European VC Funds

Bioqube Ventures is a specialist life sciences venture capital firm focused on early-stage investments in Europe, particularly in therapeutic assets and disruptive healthcare technologies. Founded in 2016 by Debora Dumont and Nico Vandervelpen, the firm launched its independent fund, Bioqube Factory Fund I, in 2020. This fund, which has secured over €60 million in its initial closing, aims to support the development of breakthrough therapies by leveraging Bioqube's unique dual investment model. This model includes both traditional venture investments and a "Create" strategy, which focuses on de-risking projects before establishing new ventures. The fund's strategy is deeply rooted in supporting high-potential scientific innovations, transforming them into commercially viable biotechnologies. Bioqube has strong partnerships with prominent investors like the European Investment Fund, Johnson & Johnson Innovation, and Genmab, further bolstering its ability to drive significant advancements in the life sciences sector. The Bioqube team is composed of experienced fund managers, sector experts, and serial entrepreneurs, bringing a hands-on approach to guiding portfolio companies through their growth stages. The firm has a significant presence in Europe, with a focus on regions such as the Benelux, France, and Germany, aiming to build a new generation of leading biotech companies.

Bitkraft Ventures is a leading venture capital firm focused on gaming, esports, and interactive media. Founded in 2015 by Jens Hilgers, Bitkraft has established itself as a pioneer in the gaming and Web3 investment space. The firm invests globally, targeting early-stage companies from Seed to Series B rounds. Bitkraft's portfolio includes over 135 companies spanning six continents, with notable investments in startups like Flock Freight, FitXR, and Honeybee Health. The firm's latest fund, Bitkraft Venture Fund 3, has raised $275 million to continue supporting innovative gaming and interactive media companies. Bitkraft's investment strategy emphasizes the convergence of physical and digital worlds, a concept they refer to as "Synthetic Reality." This vision encompasses advancements in AI, VR/AR, and blockchain technologies, aiming to create immersive and interconnected experiences. The team at Bitkraft is comprised of experienced entrepreneurs and industry leaders, providing both capital and strategic guidance to their portfolio companies. With a global presence and deep industry connections, Bitkraft Ventures remains at the forefront of driving innovation in gaming and interactive media.

Bits x Bites is a Shanghai-based venture capital firm and China’s first dedicated agrifood tech investor. Founded in 2016 by Matilda Ho, the firm focuses on early-stage startups tackling the most critical challenges in the food system, including food security, safety, and sustainability. Their investments span the entire food supply chain, from farm innovations to novel food production technologies, helping to revolutionize agriculture in China and beyond. Bits x Bites manages over $100 million across its funds, with a strong emphasis on scalable technologies that can make a measurable impact on food production and environmental sustainability. Their portfolio includes companies like EAVision, which specializes in autonomous drones for complex farming terrains, and Mojia Bio, a biomanufacturing startup that produces eco-friendly nutrients for the food industry. These investments reflect the firm’s commitment to advancing solutions in precision agriculture, alternative proteins, and biomanufacturing. With a global outlook, Bits x Bites evaluates around 1,200 startups annually, targeting companies with technologies that can be applied in China. They support their portfolio companies through partnerships with industry leaders such as Syngenta and Temasek, offering access to valuable resources and markets. The firm’s multidisciplinary team of experts provides hands-on guidance to help startups scale and commercialize their innovations in the Chinese market, shaping the future of food technology in the region​.

Black Pearls VC is an early-stage venture capital firm based in Gdańsk, Poland, with a strategic focus on the Baltic Sea Region and Central Europe. They are particularly keen on deep tech startups developing unique, scalable technologies. The fund supports businesses from seed to Series A stages, with initial investments ranging from €100k to €1m and follow-on investments up to €3m. The firm has a sector-agnostic approach but has made significant strides in digital health, enterprise software, fintech, and deep tech. Notable portfolio companies include Nanoxo, a developer of non-toxic quantum dots for various industries; Xopero, specializing in data protection solutions; and Prosoma, which offers digital therapeutics for cancer patients​. Black Pearls VC's investment strategy emphasizes collaboration, often co-investing with other prominent funds. They focus on backing entrepreneurs with groundbreaking ideas and providing extensive support through their global network of advisors and partners. The team includes experts like Managing Partner Marcin P. Kowalik, who brings a wealth of experience in corporate finance and investment management. For startups looking to attract Black Pearls VC, it is essential to highlight the scalability and uniqueness of their technology. Approaching them through detailed pitches that align with their deep tech focus can significantly increase the chances of securing funding.

BlackSheep Ventures is a Milan, Italy-based European venture capital fund founded in 2020, dedicated exclusively to Vertical AI, Sovereign AI, and AI-native software. The firm is a regulated Alternative Investment Fund Manager (AIFM) and backs outlier founders building domain-specific AI companies that bring artificial intelligence capabilities into defined industry verticals rather than competing as horizontal AI platforms. BlackSheep leads rounds at Series A and B stages, writing checks typically between $3 million and $20 million. Across two funds, BlackSheep has made 12 investments, achieving 3 exits and backing 1 unicorn. The portfolio reflects the firm's conviction that the most durable AI companies will be those that own a specific vertical with deep workflow integration and proprietary data advantages — rather than those building general-purpose models or broad platforms. The firm's Sovereign AI thesis also reflects a distinctly European perspective on the need for AI capabilities that operate within regional data sovereignty and regulatory frameworks. BlackSheep Ventures represents the growing maturity of European AI investment, moving beyond early-stage seed bets into the growth capital required to scale vertical AI companies into enterprise customers. By positioning as a specialist in domain-specific and sovereignty-aligned AI, the firm differentiates from generalist European technology funds and US-focused AI investors. Its Milan base and AIFM registration make it well positioned to engage with the broader European institutional investor community while sourcing deals across the continent's emerging AI founder ecosystem.

Blindspot Ventures is a seed-focused venture capital firm based in Boston, specializing in backing visionary founders who are reshaping industries through platform technologies and infrastructure innovation. The firm is known for partnering with bold, iconoclastic entrepreneurs who challenge the status quo and develop foundational technologies that drive industry evolution. Their portfolio includes cutting-edge companies like Form Energy, Mori, bloXroute, and Volta Labs, all of which are pioneers in fields ranging from renewable energy storage to advanced material science. Blindspot primarily invests in early-stage companies, with a typical check size of $500K to $3M. Their geographic focus is predominantly on the U.S., leveraging Boston’s rich history of innovation and proximity to top-tier academic institutions. Blindspot actively supports its portfolio companies, often taking board seats and offering strategic advice to foster long-term partnerships. Led by managing partners Ahmed Hentati and Hassan Dayekh, Blindspot is driven by a passion for addressing critical global challenges. Hentati, deeply ingrained in Boston’s startup ecosystem, focuses on identifying and backing groundbreaking founders, while Dayekh manages operations and co-leads the investment committee, bringing extensive experience from his background in banking and growth-stage venture capital.

Bloc Ventures is a specialist deep tech investor founded in 2013 by Bruce Beckloff and David Leftley, both veterans of ARM and Vodafone. The firm focuses on early-stage investments in European deep tech companies, particularly those working in cloud computing, connectivity, data science, and security. They aim to support ambitious entrepreneurs building products with the potential to impact entire industries. Bloc Ventures has a robust portfolio of companies, including Helix Geospace (precision antennas), Mindtrace (AI software), Paytia (cloud-based PCI compliance solutions), Pharrowtech (RF semiconductor technology), and Shield-IoT (IoT security platform). These investments highlight Bloc's commitment to advancing technologies that enable significant industry advancements. The firm recently raised over €23.9 million to fund early-stage deep tech startups in Europe, led by IPGL Limited and supported by industry leaders. This funding will support new portfolio additions and follow-on investments, aligning with Bloc’s strategy to scale companies of global significance. Bloc Ventures is headquartered in London and is recognized for its expert-led funding approach, combining technological, commercialization, and financial expertise to help startups reach their full potential. The team includes professionals with extensive backgrounds in the tech industry, venture capital, and company management, ensuring a hands-on and supportive partnership for their portfolio companies​

Blockchain Capital, founded in 2013 and based in San Francisco, is a pioneering venture capital firm focusing exclusively on blockchain technology and the crypto ecosystem. The firm manages multiple funds, with the most recent being Blockchain Capital Fund V, which closed at $300 million. Notable investors in this fund include PayPal and Visa. The firm has invested in over 110 companies and protocols, including prominent industry leaders such as Coinbase, Kraken, Anchorage, and OpenSea, as well as DeFi innovators like Aave, Nexus Mutual, and UMA. Blockchain Capital's investment strategy targets blockchain infrastructure, decentralized finance (DeFi), non-fungible tokens (NFTs), and emerging applications of blockchain technology. The leadership team, led by co-founder and managing partner Bart Stephens, emphasizes leveraging their extensive network, research capabilities, and industry contacts to support and grow their portfolio companies. The team has expanded to 15 members, including the recently promoted partner, Aleks Larsen.

Blockchain Valley Ventures (BVV) is a Zug, Switzerland-based accelerator and venture firm founded in 2018, located in the heart of Crypto Valley — one of the world's most established regulatory and commercial hubs for blockchain and digital assets. BVV was spun off from Lykke Corporation, a pioneer in blockchain-based trading, and operates with offices in Zug, Zurich, Singapore, and London. The firm incubates, develops, and invests in blockchain-enabled businesses that solve operational and financial inefficiencies through distributed ledger and tokenization technologies. BVV has made 22 investments across blockchain and Web3, fintech, software, security, and gaming. Portfolio companies include Measure Protocol (decentralized data marketplace), CYSEC (cybersecurity), and EX Interactive Gaming. The firm targets early-stage ventures where teams have formed and market validation is underway, employing a hybrid financing strategy that combines traditional venture capital structures with Security Token Offering (STO) mechanisms. BVV has since been rebranded as part of yabeo Emerging Tech. BVV's location in Zug is a genuine strategic asset: Switzerland's favorable regulatory framework for digital assets, its concentration of blockchain-native companies and talent, and its established financial infrastructure create a uniquely productive environment for blockchain venture activity. By bridging traditional finance with blockchain-enabled business models and operating across four international offices, BVV is positioned to support portfolio companies as they navigate the complex regulatory and commercial landscapes across Europe and Asia.

Blossom Capital, founded in 2017 and headquartered in London, has quickly established itself as a leading Series A investor in Europe. Led by Ophelia Brown, Imran Ghory, and Alex Lim, Blossom Capital focuses on high-potential sectors such as fintech, consumer internet, Web3, and enterprise SaaS. Notable investments include Moonpay, Checkout.com, Fat Llama, and Tines, demonstrating their knack for backing innovative startups. Blossom's strategy emphasizes deep, hands-on involvement, limiting investments to 5-6 Series A rounds per year to provide focused support. This approach includes assisting with recruitment, go-to-market strategies, and subsequent fundraising efforts. They prioritize building strong, long-term relationships with founders, often spending months getting to know them before committing to an investment​. The firm has a robust track record, with portfolio companies like Checkout.com and Moonpay achieving significant growth and valuations. Blossom's $432 million third fund, raised from prominent US and European investors, underscores their commitment to nurturing Europe's tech ecosystem​. For startups seeking to partner with Blossom, the key is demonstrating a clear vision and potential for substantial market impact. They value founders who are not only innovative but also resilient and prepared to scale efficiently. Blossom’s team, known for their rigorous support and strategic insight, is dedicated to propelling their portfolio companies to new heights.

Blue Bear Capital is a venture capital firm that invests in high-growth technology companies across the energy, infrastructure, and climate industries. The firm focuses on the digitization of the traditional energy supply chain, the industrialization of renewable energy, and the development of data-driven grids. Key investment themes include leveraging machine learning, industrial internet, and cloud computing technologies to create smarter, more efficient energy solutions​. Blue Bear Capital has a strong team with diverse expertise in energy private equity, technology, and entrepreneurial ventures. Partners like Ernst Theodor Sack, Vaughn Blake, and Carolin Funk lead the firm with extensive backgrounds in energy and technology domains​ (Blue Bear Capital)​. The firm's advisory board includes notable figures such as Lord John Browne, who bring additional industry insight and experience. The firm’s portfolio includes companies like First Resonance, which enhances manufacturing software principles, Urbint, an AI-driven safety risk prevention platform, and EnMass Energy, which optimizes waste-to-value supply chains. Other notable investments are Demex, providing climate-linked risk management, and Pani Energy, focusing on industrial AI for water treatment efficiency

Blue Horizon Ventures, founded in 2018 by Roger Lienhard and Michael Kleindl, is a venture capital fund focusing on food technology with a mission to drive sustainability and innovation in the food industry. Their notable investments include Alpha Foods, Love Raw, Veestro, The LiveKindly Co., Clara Foods, and TIPA, which are leading the charge in plant-based and sustainable food solutions. The firm invests primarily in alternative proteins, cultivated food, synthetic biology, and sustainable food system innovations, including smart packaging and food waste reduction. Geographically, Blue Horizon Ventures operates on a global scale, with investments in Europe, North America, and beyond, but maintains a particular focus on European and US markets​. Blue Horizon Ventures typically invests in Series A and B rounds, with ticket sizes ranging from EUR 300K to 25M over the lifespan of a company. They aim to take significant minority stakes, often between 10-30%. The fund also co-leads investments and provides substantial follow-on capital to support their portfolio companies' growth​. The team is bolstered by seasoned entrepreneurs and industry experts, including Brendan Brazier, a former professional Ironman and co-founder of Vega, who joined as a Venture Partner​​. Blue Horizon Ventures is committed to fostering innovation by partnering with ambitious and disruptive entrepreneurs who are poised to transform the food system for a sustainable future.

Blue Horizon is a Zurich-based venture capital firm focused on investing in the future of food. Founded in 2016 by Bjoern Witte and Roger Lienhard, the firm has established itself as a leader in the sustainable food sector, managing over $850 million in assets and investing in more than 60 companies globally. The firm primarily targets the alternative protein and food technology industries, with notable investments in companies like Impossible Foods, Mosa Meat, and Planted. These investments reflect Blue Horizon's commitment to pioneering innovations that promote sustainability and environmental responsibility. Mosa Meat, for instance, developed the world’s first lab-grown beef burger, while Planted is a notable player in the vegan meat market. Blue Horizon’s investment strategy emphasizes a full lifecycle approach, supporting companies from seed stage through to significant growth phases. They focus on businesses that offer transformative solutions to global challenges in the food system, such as reducing reliance on traditional meat and dairy production, and promoting plant-based and cultured food alternatives. For startups looking to connect with Blue Horizon, demonstrating a strong alignment with their mission of creating a sustainable food system and showcasing innovative solutions that address significant market opportunities are key to forming a successful partnership.

Blue Ocean Partners, managed by SWEN Capital Partners, is a pioneering venture capital firm dedicated to restoring ocean health through impactful investments. Launched in 2021, Blue Ocean has quickly become the world’s largest ocean-focused venture fund, closing at €170 million in 2023, far exceeding its initial target of €120 million. The fund targets startups that are developing innovative solutions to combat key challenges facing the oceans, including overfishing, pollution, and climate change. The fund’s portfolio includes a diverse range of companies that are driving significant environmental impact. For example, ECOsubsea offers environmentally friendly in-water hull cleaning services that reduce carbon emissions and prevent the spread of invasive species. Another portfolio company, BlueNav, develops hybrid electric propulsion systems that help reduce the carbon footprint of marine transportation. Additionally, Avant is pioneering the production of cultivated seafood, offering a sustainable alternative to traditional fishing practices. Blue Ocean Partners is committed to generating both financial returns and measurable environmental outcomes. The fund’s investments are aligned with global efforts to regenerate marine ecosystems and contribute to the broader movement of sustainable ocean innovation. As a co-founder of the 1000 Ocean Start-ups initiative, Blue Ocean Partners plays a key role in scaling transformative ocean-focused technologies globally, further solidifying its leadership in the ocean impact investing space.

Blue Wire Capital, established in 2013, is a London-based venture capital firm that focuses on early-stage investments, particularly in the pre-seed and seed stages. The firm invests across industries such as business software, environmental services, and educational technology. Notable portfolio companies include Climate X, Five, and Praktika.ai. Geographically, their investments are concentrated in Europe, with a strong presence in London. Blue Wire Capital's strategy emphasizes supporting visionary entrepreneurs addressing global challenges through technology. They typically lead investment rounds, with average check sizes around $5.96 million. They are active, engaging in 2-6 deals annually, and maintain a flexible approach to capital deployment. The team includes Bertie Highmore, Head of Investments, who brings experience from Goldman Sachs and Susquehanna International Group. To approach Blue Wire Capital, startups are advised to demonstrate innovative solutions with significant impact potential. The firm values fast and flexible access to capital, providing not just funding but also strategic support and networking opportunities to foster entrepreneurial success.

BlueOcean Ventures is a Geneva, Switzerland-based venture capital firm founded in 2007 by four partners — Faris Sabeti, Emmanuel de Watteville, Sacha Haymoz, and Thomas Zehnder — who collectively bring decades of experience building, managing, and coaching high-tech startups. The firm concentrates exclusively on early-stage medical device and life science companies across Europe, deploying check sizes of $1 million to $5 million at seed and early stages across 23 investments to date. BlueOcean leads rounds and has backed companies spanning healthtech, biotech, and diagnostic robotics. Fund II — which became the first tokenized medtech VC fund through its STO platform SwissVCToken — invested in five companies: Ava (named Switzerland's best startup in 2017/2018), Rheon Medical (adjustable glaucoma drainage device), Volumina Medical, Luciole Medical, and Abionic. Other portfolio companies include MIKAJAKI (ophthalmic diagnostic robotics, CHF 2.4M+ pre-Series A), nPloy, and CyanoGuard. Co-founder Sacha Haymoz previously co-founded PharmARC, a 300-person firm sold to IMS Health in 2012; Emmanuel de Watteville has coached over 200 high-tech startups since 2003. BlueOcean Ventures targets untapped market segments where capital scarcity and clinical complexity create a barrier that experienced domain partners can bridge. The firm supports portfolio companies with an extensive expert network and industry contacts, aiming to place capital where it addresses unmet medical needs rather than crowded, well-funded niches.

bmp Ventures is a seasoned venture capital firm based in Berlin, Germany, with over 25 years of experience in early-stage and growth investments. Since its founding in 1997, bmp Ventures has managed 11 venture capital funds and made more than 250 investments, resulting in over 120 exits and more than 20 IPOs. The firm focuses on investing in innovative and scalable companies across various sectors, including digital solutions, industry & deeptech, media & gaming, life sciences & eHealth, cleantech & planet positive, mobility & automotive, and fintech & legaltech​. They typically invest between €350,000 to €3 million in seed and early-stage rounds, with the potential to invest up to €10 million per company through subsequent financing rounds. bmp Ventures is known for being a hands-on investor, providing extensive support to their portfolio companies. This includes strategic advice, networking opportunities, assistance with business model refinement, and guidance on fundraising and exit strategies​.

BMW i Ventures is a venture capital firm focused on investing in innovative startups that shape the future of mobility and sustainability. Established in 2011, the firm has made over 50 investments in various sectors including transportation, manufacturing, supply chain, and sustainability. Their investment strategy covers a broad spectrum from seed to growth stages, with a focus on Series A and B rounds. Key portfolio companies include ChargePoint, a leading electric vehicle charging network; Solid Power, which develops solid-state battery technology; and Recogni, which designs power-efficient inference engines for edge-based sensors. Other notable investments include Proterra (electric buses), PureCycle (plastic recycling), and Tekion (automotive retail platform). BMW i Ventures recently announced the creation of a new $300 million fund aimed at early to mid-stage startups operating in sustainability and related sectors. This fund, BMW i Ventures' second, continues their commitment to advancing frontier technologies in the automotive sector while emphasizing environmental responsibility.

The Boehringer Ingelheim Venture Fund (BIVF) is a €350 million evergreen corporate venture fund of Boehringer Ingelheim, one of the world's largest family-owned pharmaceutical companies. Founded in 2010 and headquartered in Ingelheim am Rhein, Germany, with additional offices in the United States and China, BIVF invests in groundbreaking, therapeutics-focused biotechnology companies to drive innovation in biomedical research. The fund's capital base has grown substantially since inception, more than doubling through successive expansions that reflect Boehringer Ingelheim's deepening commitment to external innovation. BIVF leads rounds from seed through Series B, deploying checks between $3 million and $30 million, and has built a portfolio of over 40 companies with 6 exits back to the Boehringer Ingelheim parent. The fund's scientific focus spans first-in-class, disease-modifying therapeutics across immuno-oncology, regenerative medicine, infectious diseases, and digital health. The investment thesis prioritizes unprecedented therapeutic concepts addressing high medical need rather than incremental improvements on existing mechanisms. BIVF's evergreen structure distinguishes it from fund-cycle-constrained investors, allowing it to support portfolio companies across the extended development timelines that novel therapeutics require. The fund's global presence across Europe, the US, and China enables it to source and support biotechnology innovation wherever it originates. Portfolio companies benefit from Boehringer Ingelheim's deep expertise in clinical development, regulatory affairs, and pharmaceutical manufacturing — resources that can meaningfully accelerate the translation of early science into approvable therapies.

Boerse Stuttgart Digital Ventures (BSDV) is the corporate venture capital arm of Börse Stuttgart, Germany's second-largest stock exchange. Founded in 2017 as a wholly-owned subsidiary of Boerse Stuttgart GmbH and headquartered in Stuttgart, the firm invests in fintech startups developing innovative business models across exchange trading, OTC trading, and the digitization of financial services. BSDV's focus spans predictive data analytics, financial software, blockchain and crypto, with an international orientation that includes Scandinavian markets. The firm's most active period was 2017 to 2018. Key investments include Debtvision (financial software, April 2018) and Sowa Labs, acquired in 2017 — an AI-powered predictive analytics company that went on to develop BISON, a cryptocurrency trading app that brought crypto to mass-market retail users as a free-to-use platform. BSDV has made six recorded investments across fintech, data analytics, and AI. CEO Dr. Ulli Spankowski leads the venture, bringing a decade of exchange industry and fintech expertise. BSDV operates at the intersection of capital markets infrastructure and digital innovation, backing companies that can complement or extend the Stuttgart exchange group's core trading and data businesses. By leveraging the parent group's regulatory relationships, market access, and institutional credibility, the CVC offers portfolio companies a route to rapid adoption within the financial services ecosystem.

Boğaziçi Ventures, established in 2015 and headquartered in Istanbul, Turkey, is a venture capital firm focusing on early-stage investments in technology-driven sectors. They target industries such as fintech, health tech, retail tech, and gaming, aiming to support innovative startups that can achieve substantial growth and impact. Notable investments by Boğaziçi Ventures include Cerebrum Tech, a company specializing in digital transformation solutions, and Hiwell, an online therapy platform. They have made 59 investments, primarily within Turkey, but also in regions like the United Kingdom and the United States. The firm is led by co-founders Barış Özistek and Burak Balık, who, along with their team, emphasize sustainable development goals in their investment strategies. Boğaziçi Ventures supports its portfolio companies with not only financial backing but also strategic guidance to help them scale effectively.

BOLD (Business Opportunities for L'Oréal Development) is L'Oréal's strategic venture capital fund, established in 2018. Focused on redefining the future of beauty, BOLD invests in startups that are pushing the boundaries of innovation in beauty brands, beauty platforms, tech for beauty, and science for beauty. Notable investments include Digital Village, a metaverse-as-a-service platform; Debut, a biotech company revolutionizing ingredient manufacturing; and Timeline, a Swiss longevity biotech company. These investments highlight BOLD's commitment to integrating cutting-edge technology and sustainable practices into the beauty industry. Geographically, BOLD operates globally, leveraging L'Oréal's extensive network to provide startups with unparalleled access to resources and expertise. Their investment strategy centers on strategic minority stakes in companies that align with L'Oréal's innovation goals, particularly in sustainability and advanced beauty tech. BOLD typically leads investment rounds, offering both capital and mentorship to foster growth. They focus on startups with innovative solutions that meet unmet consumer needs and promote sustainable practices. Entrepreneurs can approach BOLD through their website, where they can pitch their ideas and potentially join BOLD's diverse portfolio. The fund is spearheaded by a team of experts, including Barbara Lavernos, Deputy CEO in charge of Research, Innovation, and Technology, who emphasizes a multidimensional approach to beauty and longevity.

BOLD (Business Opportunities for L'Oreal Development) is the global corporate venture capital fund of L'Oreal, the world's largest beauty company. Founded in 2018 and headquartered in Clichy, France, BOLD explores the frontier of beauty through strategic minority investments in promising startups across the beauty value chain. The team of nine includes three Partners and four Principals based in France. The fund leads rounds and has invested across 19 companies with 31 total investments including follow-on rounds. BOLD invests across seed, Series A, and Series B stages with check sizes from $1 million to over $10 million depending on the round. Notable investments include Debut (synthetic biology for cosmetics ingredients, where BOLD led a $40 million Series B), Timeline (a Swiss longevity biotech company that holds the proprietary Mitopure molecule, where BOLD led a $66 million Series D alongside Nestle), Carbios (plastic recycling biotech that IPO'd on Euronext), BORNTOSTANDOUT (fragrance brand), SPARTY (personalized beauty D2C from Japan, invested May 2022), and Live Tinted (personal products, most recent investment February 2026). Gjosa, a water-saving technology company, was acquired. Global Bioenergies also IPO'd from the portfolio. Investment themes span sustainable beauty, clean and natural beauty, health and wellness, beauty tech, green science, data management, and Web3 applications. BOLD's strategic value to portfolio companies extends far beyond capital. Startups gain access to L'Oreal's 110 years of beauty heritage, global R&D capabilities spanning 35 research centers in 10 countries, worldwide distribution infrastructure, and proprietary consumer insights across all beauty categories. This makes BOLD a uniquely strategic partner for founders building at the intersection of science, technology, and beauty.

Brabantse Ontwikkelings Maatschappij (BOM), based in Tilburg, Netherlands, is a venture capital firm dedicated to fostering innovation and economic growth in the Brabant region. Since its founding in 1983, BOM has been actively investing in startups and scale-ups across various sectors including renewable energy, high-tech systems, agro-food, life sciences, and med-tech. BOM has built a significant portfolio with notable investments in companies like Sirius Medical Systems, which enhances cancer treatment with precise surgical solutions, and AvL Motion, known for developing a robotic asparagus harvester. Another key investment is in LionVolt, which focuses on developing sustainable 3D solid-state batteries. BOM is recognized as the most active venture capital investor in Dutch startups, highlighting its commitment to driving economic impact and innovation in the region. Their strategic approach includes providing financial support and expertise to startups, ensuring these companies can grow effectively and sustainably. This proactive involvement has led to successful exits and significant contributions to societal transitions such as climate-neutral energy solutions and advancements in health technology. With a focus on creating a robust entrepreneurial ecosystem, BOM continues to support and invest in companies that have the potential to make substantial contributions to the Brabant economy and beyond.

Bonnier Ventures — now operating as Bonnier Capital — is the venture arm of the Bonnier Group, a Swedish family-owned media, publishing, and real estate conglomerate active across 12 countries. Launched in Stockholm in 2013 as Bonnier Growth Media, the firm makes minority investments in fast-growing digital technology companies at seed through Series B stages, with a primary focus on the Nordic market and global ambition. Bonnier Capital manages approximately 3 billion SEK (roughly $280 million) in assets and has made 52 investments, producing one unicorn, one IPO, and six acquisitions. Typical deal sizes range from $5 million to $10 million, with average round investments of approximately $16 million. The portfolio spans media, entertainment, edtech, health, and food tech, and includes MasterClass (online education platform, unicorn), Acast (global podcast platform), Doktor.se (digital healthcare), Natural Cycles (FDA-cleared fertility app), Toca Boca (children's digital toys), and MatHem (online grocery delivery). The most recent investment was Carla, a Series A completed in January 2025. Bonnier Ventures draws on the parent group's century-long presence in media and publishing to offer portfolio companies access to editorial networks, distribution channels, and content partnerships that pure financial investors cannot replicate. The six-person investment team evaluates opportunities through the lens of long-term brand building and sustainable digital growth.

Bonsai Venture Capital — now operating as Bonsai Partners — is a Madrid-based venture capital firm founded in 1999 by Javier Cebrián Monereo, making it one of Spain's most established early-stage investors. Formed through the merger of Bonsai Venture Capital and Cube Ventures, the firm has a presence in both Madrid and Barcelona and manages approximately $259 million in assets. The most recent fund, Bonsai Partners IV, secured €120 million in commitments. Bonsai leads rounds, investing $2 million to $6 million primarily in marketplace and SaaS businesses across Spain and Europe, and has completed 78 investments to date. The portfolio has produced one unicorn in Glovo, which was acquired by Delivery Hero, and notable exits including Wallapop (acquired by Naver for $695 million in August 2025), idealista, Returnly (sold to Affirm), and Signaturit (sold to PSG). Active portfolio companies include Exoticca, Lookiero, Sendcloud, Trucksters, Casavo, Refurbed, GoTrendier, and Solfy Renewables. Recent 2025 and 2026 deals include Rail-Flow (€12.5 million co-led, December 2025), Lookiero Outfittery Group (€17 million, January 2026), and RepScan (€3.5 million, January 2026). Bonsai is led by a management team of 14 — including 10 partners — with over 80 combined years of venture expertise. The firm has built its franchise on supporting internet and digital companies at the critical inflection points where operator discipline and founder alignment determine which European startups scale to regional and global leadership.

BonVenture is a Munich-based venture capital firm specializing in social impact investments. Founded in 2003, the firm focuses on supporting early-stage startups that aim to address social and environmental challenges. BonVenture's investment strategy is centered around social enterprises in the German-speaking region, emphasizing sectors such as renewable energy, health care, and environmental sustainability. Notable investments include Resourcify, a digital waste management and recycling platform; myo, a communication platform for caregivers; and ChargeX, which develops smart power strips for connecting multiple electric vehicles to a single charging station. Other significant investments include Wegatech Greenergy, a residential solar energy system project developer, and 42 Watt, a company specializing in energy efficiency and environmental consulting. BonVenture actively participates in various funding rounds, providing capital and strategic support to help social enterprises scale their impact. The firm has a track record of successful exits, including Emmy, an e-scooter sharing company, and Everskill, a digital training platform. With a commitment to fostering innovation and sustainability, BonVenture continues to support startups that align with its mission of creating positive social and environmental change. The firm leverages its extensive network and industry expertise to help portfolio companies achieve their growth and impact goals.

Boost VC, founded by Adam Draper and Brayton Williams in 2012, is a venture capital firm based in San Mateo, California, that focuses on early-stage investments in frontier technologies. With over $200 million in assets under management, Boost VC typically invests $500,000 in pre-seed startups, supporting over 300 companies. Their portfolio includes notable companies like Coinbase, Protocol Labs, and Snapcard, and spans deep tech sectors such as crypto, VR, AR, AI, space tech, robotics, and bio/health. Boost VC operates a rigorous accelerator program, providing startups with mentorship, resources, and networking opportunities. The three-month program offers intensive support from the Boost VC team and access to a wide network of industry experts and investors. The firm is known for its strong commitment to fostering innovation and diversity within the tech industry, actively supporting women and underrepresented founders. Adam Draper, a fourth-generation venture capitalist, and Brayton Williams, bring extensive experience and a vision for transformative technology startups. The team includes partners like Maddie Callander and Gus Domel, who offer diverse expertise from private aviation to brain health technology.

Borski Fund is a pioneering venture capital firm based in Amsterdam that focuses on closing the gender gap in venture capital by investing in companies led by women or gender-diverse teams. Founded in 2019 by Simone Brummelhuis and Laura Rooseboom, Borski Fund is named after Johanna Borski, a 19th-century Dutch financier who was instrumental in funding the Dutch Central Bank. The fund is dedicated to supporting female entrepreneurs and teams with at least one female executive with equity stakes, aiming to foster innovation, inclusivity, and economic growth. Borski Fund’s investment thesis is centered around the belief that diversity leads to better decision-making and stronger business outcomes. The fund’s portfolio includes companies across various sectors, including technology and sustainability, with a particular focus on those driven by data and AI. Borski Fund also stands out due to its collaboration with major partners like the Visa Foundation, which recently contributed to expanding the fund to €40 million. This partnership reflects a shared commitment to promoting gender equality in the startup ecosystem, and the fund has made significant strides in empowering women-led businesses across Europe. By creating opportunities for women and gender-diverse teams, Borski Fund is not only addressing the significant investment gap in venture capital but also championing a more equitable and inclusive business environment.

Bose Ventures is the corporate venture capital arm of Bose Corporation, headquartered in Framingham, Massachusetts. Founded in 2015, the fund has up to $50 million allocated for investing in startups building apps, services, or technologies adjacent to the Bose AR platform and broader audio technology ecosystem. The CVC focuses on three core areas — wearables, wellness, and audio — and has made 20 investments across seed through Series B in companies operating in the United States and Europe. The portfolio has produced one unicorn in Whoop (connected fitness wearables), one IPO in Acast (global podcast platform), and five acquisitions including Aaptiv (fitness audio, acquired by Bose). Other portfolio companies include Noise (consumer electronics, most recent investment April 2025), Bragi (wireless earbuds), Beekeeper (B2B workforce productivity), hearX Group (hearing health, led an $8.3 million round), and MedRhythms (digital therapeutics for neurological conditions). As a strategic CVC, Bose Ventures offers portfolio companies access to Bose's engineering teams, acoustic technology platform, global retail and distribution network, and brand credibility — resources that translate into product development advantages and faster paths to market. Managing Director Steve Romine oversees the fund's investment activities. The firm's thesis centers on the belief that audio and sensory technologies are foundational infrastructure for the next generation of health, fitness, and communication products.

Bossanova Investimentos, often referred to as Bossanova Invest, is a prominent venture capital firm based in Brazil, specializing in pre-seed stage investments. Founded in 2011 by Pierre Schurmann and later joined by João Kepler, Bossanova has established itself as the most active micro-VC in Latin America. The firm focuses on B2B and B2B2C technology companies that are innovative, digital, and scalable​​. Bossanova has invested in over 1,200 startups across more than 1,000 companies, making it a significant player in the early-stage investment scene. Their portfolio includes notable exits such as Glovo, Upsie, and Shift​​. They employ a rigorous selection process and offer extensive support to their portfolio companies to ensure rapid growth and success. The firm's investment strategy revolves around startups that are over 1.5 years old, have found a problem-solution fit, and are already operational and generating revenue. They avoid investments in sectors that exclusively target government, e-commerce, games, or hardware that competes with existing portfolio companies​. Bossanova's network includes over 10,000 co-investors, founders, and partner companies, providing a robust ecosystem for startups to thrive. They also offer educational resources through platforms like Clubb.vc, which provides courses and materials on investment, innovation, and business development​​. In addition to traditional equity investments, Bossanova has introduced an innovative investment model via Cédula de Crédito Bancário (CCB), which allows investors to gain exposure to the startup ecosystem with capital protection and fixed returns​​. This approach aims to democratize access to venture capital investments, making it accessible to a broader range of investors.

Boundary Capital is a London-based venture capital firm focused on impact investing in early-stage companies that aim to improve lives and deliver strong commercial returns. Their investment strategy centers on technologies in life sciences, engineering, and data science that address critical global challenges such as healthcare, sustainability, and education. By aligning economic success with positive societal impact, Boundary Capital looks for businesses that offer innovative solutions to real-world problems. The firm typically invests in businesses from late seed to Series B stages, targeting returns of 3x within five to seven years. They place a strong emphasis on companies with proven economic potential and intellectual property advantages. Their portfolio includes high-growth companies like Glyconics, which is developing diagnostics for chronic lung diseases, and Echion, which focuses on fast-charging battery technology. Boundary's team combines extensive entrepreneurial and investment expertise. Led by Managing Partner Dan Somers, the firm supports portfolio companies with strategic guidance, leveraging both their financial investment and hands-on operational support.

Bouygues Développement, established in 2009, is the corporate venture capital arm of the Bouygues Group. It focuses on minority investments in startups that align with the group's diverse business sectors, including construction, real estate, media, and telecoms. Bouygues Développement supports Bouygues Construction, Bouygues Immobilier, Colas, TF1, and Bouygues Telecom in their innovative endeavors. Their investment strategy primarily targets Seed and Series A funding rounds, with initial investments ranging from €100,000 to over €1,000,000. Bouygues Développement aims for equity stakes between 5% and 20%, ensuring a strategic partnership and often securing a board seat to foster close collaboration. Bouygues Développement has built a robust portfolio that includes startups such as Construction Venture, Bouygues Immobilier Recherche et Développement, and Bouygues Telecom Initiatives. These investments reflect their commitment to innovation across their core industries. The team is led by Benoît Michard, Director of Bouygues Développement, who joined the group in 2015 and assumed his current role in 2021. The team also includes Maxime Paghent and Charles-Antoine Saltiel, both responsible for participations and bringing extensive experience in corporate law, finance, and strategic investments. Diane Fiocca, an analyst specializing in venture capital, joined in 2023, bringing expertise from her work with deeptech startups. Bouygues Développement's approach emphasizes strong, enduring relationships with entrepreneurs, providing not only financial support but also strategic guidance to drive successful project outcomes.

BoxOne Ventures, established in 2018 and based in Montreal, Canada, is a venture capital firm that focuses on early-stage investments across diverse and impactful sectors. The firm invests in companies with strong technology platforms in areas such as biotechnology, computational biology, AI and data analytics, digital health, fintech, and food technology. BoxOne Ventures has built a robust portfolio featuring notable investments like Juvena Therapeutics, which raised $41M to advance therapeutic solutions. Other significant investments include companies like dfuse, a blockchain development platform, and Odd Burger, a plant-based fast food chain. The firm’s strategy includes backing talented entrepreneurs and innovative technologies that aim to make a positive difference globally. The team at BoxOne Ventures comprises experienced founders and investors who are deeply involved in the development and support of their portfolio companies. This hands-on approach helps startups navigate the challenges of scaling and achieving market success.

New Science Ventures (NSV), founded in 2004, is a venture capital firm that focuses on investments in life sciences and information technology. With offices in New York and London, NSV aims to leverage breakthrough science to create significant value. The firm has a diverse portfolio, investing in companies that utilize fundamental, science-based innovations to address large unmet needs. NSV's notable investments include Ventyx Biosciences, which raised $114 million to advance its pipeline of immunology programs, and Paragraf, a company that mass-produces graphene electronics. Other significant portfolio companies are Phase Four, which develops next-generation electric propulsion solutions for satellites, and NorthSea Therapeutics, which focuses on novel treatments for liver-related diseases​. The firm typically invests in early to mid-stage companies and supports them through crucial value inflection points to help them scale. Their investment strategy is grounded in strong intellectual property protection and a long-term view​.

Bpifrance is a French state-backed investment bank focused on fostering innovation and entrepreneurship. Its venture capital arm covers a wide range of sectors, investing in startups at all stages—seed, early, and late stage, as well as growth. Bpifrance has made significant contributions to sectors like life sciences, digital technology, and green energy, aiming to support French companies in becoming global market leaders. One of its flagship initiatives is the Large Venture fund, which invests in fast-growing, capital-intensive companies, with typical investments starting at €10 million in rounds of €20 million or more. Notable investments include Doctolib, a leader in the European e-health sector, and Devialet, known for its groundbreaking audio technology. Bpifrance’s investment strategy emphasizes economic impact alongside financial returns, enabling it to take more risks compared to traditional private investors. It also prioritizes areas like climate tech and deep technology, where it sees gaps in venture capital attention. The firm operates both domestically and internationally, with €17 billion in assets under its Funds of Funds division, backing numerous European and global venture capital firms. Bpifrance’s dual mission—to generate returns and spur innovation—makes it a vital player in Europe’s venture capital ecosystem​.

Brandtech Ventures is the strategic venture investment arm of The Brandtech Group, the world's first 'brandtech' holding company founded in June 2015 by former Havas Global CEO David Jones as You & Mr Jones and rebranded to The Brandtech Group in January 2022. Based in New York, the Group helps global brands market better, faster and cheaper by combining owned operating companies, such as the generative-AI marketing platform Pencil, with a portfolio of strategic minority investments in the technologies most likely to reshape brand marketing. Brandtech Ventures invests at Seed, Series A and Series B across adtech, martech, generative AI, big data and analytics, AR/VR and the metaverse, influencer marketing and gaming. Its portfolio of roughly 26 named investments includes Niantic, the Pokémon GO creator the firm backed as one of the earliest external investors after its 2015 spinout from Google, alongside Crossing Minds, Zappar, Jivox, Automat, Elsy, VidMob, CreativeX, AI Foundation, Provenance and Pixlee-TurnTo. The Brandtech Group raised a $115M Series C in March 2024 at a $4 billion valuation from Fimalac and NendoLabs alongside Mousse Partners and Bansk Group, bringing total Group capital raised to roughly $373 million. Leadership includes founder and CEO David Jones, Global CFO Matthieu Pigasse, the former Lazard banker who joined in 2024, and Partner and Head of Emerging Technologies Rebecca Sykes. As a strategic investor rather than a lead, Brandtech Ventures pairs capital with the Group's operating platform to commercialise the next generation of marketing technology.

Break Off Capital is a dynamic investment firm dedicated to expanding human potential through science and technology. Their mission is driven by the "Break Off" phenomenon—a cognitive shift in awareness recognizing the fragility of life and the imperative to protect and advance our world. The firm is committed to solving global challenges by channeling resources into cutting-edge scientific and technological advancements. Notable divisions include Break Off Capital, which focuses on funding groundbreaking scientific projects; Break Off Crowd, a platform for community-driven scientific support; and Break Off Labs, which connects researchers with funders to facilitate pioneering research. The team is led by Ricardo Celaya, who brings a wealth of experience from his background in art, finance, and private equity, and Victor Celaya, who has a strong background in media and innovation. They are supported by a network of corporate and scientific advisers, including Shervin Kamkar from Illumina and Dr. Leslie Dewan, a nuclear engineer and conservation technologist. Break Off Capital invests in early-stage ventures that address significant societal issues, emphasizing collaboration and strategic support to foster innovation and impact. Their approach is to integrate financial backing with expert mentorship, ensuring that startups not only receive funding but also the guidance needed to scale effectively.

Breakthrough Energy Ventures, part of the Breakthrough Energy network founded by Bill Gates, focuses on financing and scaling companies that aim to eliminate greenhouse gas emissions globally. With over $3.5 billion in committed capital, BEV invests in more than 110 cutting-edge companies across various stages, from seed to growth. The firm targets technologies capable of significantly reducing greenhouse gases, aiming for at least half a gigaton reduction annually. Key areas of investment include clean hydrogen, long-duration energy storage, sustainable aviation fuel, direct air capture, and green manufacturing. BEV supports companies like H2Pro, which innovates in green hydrogen production, and Heirloom, focused on cost-effective carbon removal. BEV’s strategy involves more than just funding; it provides comprehensive support, including technical, operational, market, and policy expertise to help companies overcome scaling challenges. This holistic approach ensures that new climate technologies can transition from development to widespread commercial adoption. The team at BEV includes experts like Eric Toone, Technical Lead of the Investment Committee, and Megan Wenrich, Vice President of Development. These professionals bring a wealth of knowledge and experience to guide the firm’s investments and initiatives.

Breega, founded in 2015 and based in Paris, is a dynamic venture capital firm built by founders for founders. They focus on early-stage investments, with a mission to bridge the equity and experience gap in the VC industry. Breega's notable investments include quantum tech startup Alice&Bob, regtech firm Didomi, and French unicorn Exotec. Breega’s industry focus spans various tech sectors, including fintech, quantum technology, regtech, green mobility, and cybersecurity. They have recently launched a €150M Europe Seed III fund to support early-stage tech startups and a $75M Africa Seed I fund to invest in promising African startups. Geographically, Breega is expanding its reach with a strong presence in Europe, particularly France, Spain, and the UK, and is now targeting markets in Africa with new offices in Nigeria and Cape Town. Their investment strategy is hands-on, providing startups with comprehensive support through their "Scaling Squad," a team of experts that assist with operational guidance, talent acquisition, and scaling strategies. Breega aims to invest in companies with the potential for significant social impact alongside commercial success. The team includes key members like Co-founder and COO Maximilien Bacot, and they are known for their collaborative approach and commitment to supporting founders throughout their entrepreneurial journey.

BrightEdge is the innovation and impact investment arm of the American Cancer Society (ACS), founded in 2018 and based in Kennesaw, Georgia. A donor-funded philanthropic impact fund, BrightEdge invests in for-profit, early-stage companies developing cancer-focused therapeutics, diagnostics, medical devices, and enabling technologies. Through the end of 2024, the fund has deployed $52 million across 22 companies, with 15 active portfolio companies holding potential to impact 13.4 million patients. The fund invests globally — across the United States, Canada, Europe, and Asia-Pacific. Investments are aligned with ten American Cancer Society mission priority areas, including cancer health equity, patient survivorship, disease prevention, clinical trial accessibility, and care quality. Recent portfolio companies include Signify Bio (in vivo therapeutics, 2024). BrightEdge also runs the BrightEdge Entrepreneurs program to support founders navigating the early stages of cancer innovation. Managing Director Alice Pomponio brings experience from Red Sky Partners and teaches biomedical innovation at MIT; Director of Investments Lucas de Breed leads deal sourcing and execution. BrightEdge distinguishes itself from pure financial investors by reinvesting all financial returns back into the American Cancer Society's scientific and patient advocacy programs, making every exit outcome directly compound the mission. The fund operates with a dual mandate: achieving genuine venture returns while ensuring the ACS remains a financially self-sustaining engine for cancer research for decades ahead.

Brighteye Ventures is Europe's first and largest dedicated edtech venture capital firm, founded in 2017 with offices in Paris, London, and Luxembourg. The firm backs founders shaping what it calls the 'HumanOS' — enabling people to learn, work, and adapt throughout their lives. Brighteye closed its second fund at €100 million, doubling Fund I and bringing total assets under management to €150 million. The firm invests €400,000 to €4 million at pre-seed through Series A, primarily in European startups using technology to enable learning, skills acquisition, or research. Brighteye leads rounds and has built a portfolio of 48 companies. Two portfolio companies have been acquired — Epic and Beekast — across a portfolio weighted heavily toward education (30 companies), SaaS, AI, and HR technology. Partners Alex Latsis and Benoit Wirz have spent over a decade building and investing in European and North American edtech, giving the six-person team a network that spans both founders and corporate buyers. Brighteye's investment thesis focuses on the intersection of learning, entertainment, and creativity — backing companies that expand human potential rather than merely digitizing existing curricula. The firm supports portfolio companies through product refinement, partnership development, and geographic expansion, drawing on long-standing relationships with European universities, enterprise L&D buyers, and media partners that would be difficult for a generalist fund to replicate.

Brightlands Venture Partners is a venture capital firm based in Geleen, Netherlands, with a strong focus on investing in startups and scale-ups that address key societal challenges in sustainability and health. Established in 2014, the firm manages several funds, including Brightlands Agrifood Ventures, BVP Fund IV, Chemelot Ventures, and Limburg Ventures, with a combined capital of approximately €120 million. The firm primarily invests in sectors like renewable chemistry, regenerative medicine, agri-food, and digital technologies, aiming to support companies that contribute to a sustainable and healthier future. Brightlands Venture Partners has a diverse portfolio of over 70 companies, including Qorium, a pioneer in cell-cultured leather, and PL BioScience, a leader in sustainable cell culture media. Their investment strategy is not only about providing capital but also involves active involvement and support in scaling the companies, leveraging their deep sector expertise. The leadership team at Brightlands includes experienced professionals like Casper Bruens, Marcel Kloosterman, and Kim de Boer, who collectively bring decades of experience in venture capital and the life sciences industry. Their approach is characterized by a strong emphasis on impact investing, aligning financial returns with measurable societal impact.

Brightly Ventures is an early-stage Nordic venture capital firm based in Stockholm, Sweden, founded in 2018. The fund, which raised 551 million SEK (approximately $55 million) and closed for new investments in September 2021, backs bold founders on a mission to transform industries across software, sustainability, gaming, AI, and food tech. Brightly invests primarily at seed stage with a typical check of $1.5 million and a range from $100,000 to $5 million, and leads rounds across its 34 portfolio companies. Managing Partner John Elvesjö co-founded Tobii, the eye-tracking technology company, before founding Brightly — a background that shapes the firm's orientation toward deep technology with commercial scale. Partner Andy Johnston brings more than 20 years of experience from Ericsson. Portfolio companies include Worldfavor (sustainability data platform), Debricked (open source security, acquired by CyberRes/Micro Focus in March 2022), Ebbot (GPT-powered customer support), Open Payments (fintech), Fast Travel Games, Artportable, Fenix Family, Hooked Foods, and Collective Minds Radiology (digital healthcare collaboration, raised SEK 25 million). Brightly's geographic concentration in the Nordic market reflects a conviction that Scandinavia consistently produces engineering-led founders who are underserved by larger pan-European funds. The team of four works closely with portfolio companies on product strategy and international scaling, drawing on deep regional operator networks to accelerate growth beyond the domestic market.

BRP-X is a venture capital firm known for its investments in the high-tech sector, particularly focusing on advanced and innovative technologies. The firm emphasizes supporting early-stage companies that demonstrate strong growth potential and the ability to disrupt traditional markets. BRP-X's notable investments include a wide array of companies across various industries. For instance, they have backed AthenaHealth, a leading cloud provider of electronic medical records and revenue cycle management solutions, and Aveanna Healthcare, a prominent pediatric home healthcare company in North America. Another significant investment is in CentralSquare Technologies, which provides public sector software solutions in the United States and Canada. The firm is also known for its involvement in consumer brands like Canada Goose, a designer and manufacturer of premium outdoor apparel, and Bob's Discount Furniture, a major furniture retailer in the Northeast US. Additionally, BRP-X has invested in Bombardier Recreational Products (BRP), a global leader in powersports vehicles and propulsion systems. BRP-X's investment strategy revolves around leveraging their deep industry expertise and extensive network to support their portfolio companies, helping them scale and achieve significant market impact. For more details on their portfolio and investment approach, you can visit their official website or review their profiles on various investment platforms.

Britbots, established by Dominic Keen in 2016, is a UK-based venture capital firm that specializes in investing in early-stage robotics, artificial intelligence (AI), and automation companies. The firm is recognized for its focus on addressing global productivity challenges through automation technologies, which it sees as critical to counteracting declining labor growth, environmental strain, and energy inefficiencies. Britbots manages several funds, including the British Robotics Seed Fund and the Scale-Up Fund, both of which are structured to take advantage of the UK government's SEIS (Seed Enterprise Investment Scheme) and EIS (Enterprise Investment Scheme) tax incentives. These funds primarily target high-potential startups that are developing cutting-edge robotics and AI technologies, with a strong emphasis on capital-efficient projects that can deliver substantial productivity gains. Notable companies in Britbots' portfolio include Muddy Machines, which develops autonomous robots for agricultural tasks, and RAD Propulsion, which creates advanced propulsion systems for the marine industry. The firm’s investments are characterized by their focus on innovative solutions that combine sophisticated software with accessible, off-the-shelf hardware, making advanced robotics more affordable and scalable. Britbots' investment strategy involves not just capital support but also active mentorship and operational guidance, helping startups navigate technical challenges and scale their innovations. This approach is designed to foster long-term growth and deliver significant returns by backing startups that are poised to become leaders in their fields.

Broadview Ventures, founded in 2008 and headquartered in Boston, Massachusetts, is a venture capital firm focused on investing in early-stage life sciences companies. The firm specializes in cardiovascular and neurovascular diseases, aiming to bridge the translational gap between scientific research and clinical application. Broadview Ventures has a robust portfolio that includes companies such as DecImmune Therapeutics, which develops therapies to mitigate injury post-myocardial infarction, and FineHeart, a French medical device company creating innovative cardiac support technologies. Other notable investments include GI Windows, developing non-surgical approaches for treating chronic diseases, and Adient Medical, focusing on absorbable medical devices. The firm has made 79 investments and achieved several successful exits, including Cardialen, VentriNova, and Renovacor. Broadview's investment strategy leverages their extensive industry expertise and network to support companies from seed through later stages of development. Broadview Ventures is led by a team of experienced professionals dedicated to advancing healthcare through innovative solutions. Their strategic focus and targeted investments aim to address unmet medical needs, ultimately improving patient outcomes and advancing the field of cardiovascular and neurovascular health.

Brooklyn Ventures is a venture builder and venture capital firm founded in 2011 and headquartered in Delft, Netherlands. The firm invests in and operationally supports companies across data intelligence, oil and gas, telecom and media, predictive analytics, and high-tech machinery. Operating as a venture builder, Brooklyn Ventures takes a hands-in role across funding, finance, legal, business development, marketing, data analysis, and IT architecture — functioning as an embedded operational partner rather than a passive capital provider. The portfolio of 11 investments includes Pandora Intelligence (AI and deep learning data intelligence, led by Partner Ard Jol), IRM Systems (pipeline inspection and maintenance services, led by Managing Director Rutger Schouten), RingCredible (which received a €550,000 Series A, run by Partner Hans Osnabrugge), and Mobile Interaction Company. Portfolio companies operate globally, with offices across Johannesburg, Dubai, Lagos, London, Houston, New Delhi, and Kuala Lumpur, reflecting Brooklyn's focus on Europe, Africa, and MENA markets. The three partners — Hans Osnabrugge, Ard Jol, and Rutger Schouten — are each actively embedded in specific portfolio companies as executives rather than board advisors alone. This structure reflects a conviction that the firm adds greatest value not by writing checks and attending quarterly reviews, but by sharing the operational burden of building early-stage companies in technically complex, capital-intensive sectors.

Black River Ventures (BRV) is a venture capital firm founded in 2013 and headquartered in Barcelona, Spain, with operations across the European Union and the United States. The firm invests in growth and later-stage technology companies with a particular focus on fintech, data analytics and AI, software and services, and hardware and IoT. BRV manages approximately $20 million in assets and provides capital in the range of $3 million to $20 million, with a typical investment ticket of $5 million to $10 million and a three-to-five-year investment horizon. The portfolio spans 11 investments, including DreamBig Semiconductor (Series B, July 2024). The firm targets both European companies aiming to become global leaders and US technology companies entering the European market, viewing the European online audience of 400 million-plus consumers as a durable and underpenetrated commercial opportunity for well-capitalized growth companies. Managing Partner Evgeny Kaltashev leads the firm with a focus on partnering with visionary growth-stage companies that have demonstrated early market leadership and are seeking smart capital for long-term expansion. BRV's investment strategy is built around a combination of financial return and active partnership — providing operational guidance, market access, and strategic introductions that help portfolio companies accelerate their paths to acquisition or public market exit.

Btomorrow Ventures (BTV) is the corporate venture capital arm of British American Tobacco, established in 2020 and headquartered in London. BTV focuses on building transformative and innovative businesses across sectors such as consumer brands, digital transformation, new technologies, and future sciences, with a strong emphasis on Environmental, Social, and Governance (ESG) criteria. BTV has made notable investments in startups like FlexSea, a UK-based company pioneering sustainable, seaweed-derived bioplastics, and Open Book Extracts, a cannabinoid innovation house in North Carolina. Their portfolio includes diverse companies such as Awake Chocolate in Canada, offering functional caffeinated chocolates, and Hesperos in Florida, known for their Human-on-a-Chip® technology​. The firm typically participates in early to growth-stage funding, with an average check size of $1 million. BTV is known for leading investment rounds and has a keen interest in companies that align with their sustainability and innovation goals. They actively collaborate with their portfolio companies through initiatives like Btomorrow Labs, providing strategic support and global distribution channels. Led by Managing Director Juan Palacios, the BTV team operates primarily from London, offering a blend of financial investment and strategic partnerships to accelerate the growth of ambitious founders and their disruptive technologies.